Acute Mortality in Hospitalized Patients Undergoing Echocardiography With and Without an Ultrasound Contrast Agent (Multicenter Registry Results in 4,300,966 Consecutive Patients)

American Journal of Cardiology

Volumn 102, Issue 12, 2008, Pages 1742-1746

  Main, Michael L ^a   Ryan, Amy C ^b   Davis, Teresa E ^b   Albano, Maureen P ^c   Kusnetzky, Lisa L ^a   Hibberd, Mark ^c  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^b Premier Inc   (United States)

^c A Subsidiary of Lantheus Holdings   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ECHO CONTRAST MEDIUM; PERFLUTREN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CRITICALLY ILL PATIENT; DEATH; DRUG SAFETY; ECHOCARDIOGRAPHY; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MORTALITY; NEWBORN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CONTRAST MEDIA; ECHOCARDIOGRAPHY; FLUOROCARBONS; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INFANT; LOGISTIC MODELS; MICROSPHERES; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 57649102570     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.08.019     Document Type: Article

References (16)

1. Mulvagh S.L., DeMaria A.N., Feinstein S.B., Burns P.N., Kaul S., Miller J.G., Monaghan M., Porter T.P., Shaw L.J., and Villanueva F.S. Contrast echocardiography: current and future applications. J Am Soc Echocardiogr 13 (2000) 331-342
2. Kornbluth M., Liang D.H., Brown P., Gessford E., and Schnittger I. Contrast echocardiography issuperior to tissue harmonics for assessment of left ventricular function in mechanically ventilated patients. Am Heart J 140 (2000) 291-296
3. Reilly J.P., Tunick P.A., Timmermans R.J., Stein B., Rosenzweig B.P., and Kronzon I. Contrast echocardiography clarifies uninterpretable wall motion in intensive care unit patients. J Am Coll Cardiol 35 (2000) 485-490
4. Yong Y., Wu D., Fernandes V., Kopelen H.A., Shimoni S., Nagueh S.F., Callahan J.D., Bruns D.E., Shaw L.J., Quinones M.A., and Zoghbi W.A. Diagnostic accuracy and cost-effectiveness of contrast echocardiography on evaluation of cardiac function in technically very difficult patients in the intensive care unit. Am J Cardiol 89 (2002) 711-718
5. Grayburn P.A. Product safety compromises patient safety (an unjustified black box warning on ultrasound contrast agents by the Food and Drug Administration). Am J Cardiol 101 (2008) 892-893
6. New U.S. Food and Drug Administration prescribing information for Definity approved October 10 2007. http://www.fda.gov/cder/foi/label/2007/021064s007lbl.pdf Accessed on July 29, 2008
7. Main M.L., Goldman J.H., and Grayburn P.A. Thinking outside the "box": the ultrasound contrast controversy. J Am Coll Cardiol 50 (2007) 2434-2437
8. United States Food and Drug Administration Center for Drug Evaluation and Research alert for healthcare providers updated on July 17, 2008. http://www.fda.gov/cder/drug/infopage/microbubble/default.htm Accessed July 29, 2008
9. Premier, Inc. home page. http://www.premierinc.com Accessed July 29, 2008
10. Averill R.F., Goldfield G., Hughes J.S., Muldoon J., Gay J., McCullough E., Bonazelli J., and Mullin R. What are APR-DRGs?. An Introduction to Severity of Illness and Risk of Mortality Adjustment Methodology (2005), 3M HealthInformation Systems, Wallingford, CT
11. Averill R.F., Goldfield N.I., Muldoon J., Steinbeck B.A., and Grant T.M. A closer look at all-patient refined DRGs. J AHIMA 73 (2002) 46-50
12. Kusnetzky L.L., Khalid A., Khumri T.M., Moe T.G., Jones P.G., and Main M.L. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent: results in 18,671 patients. J Am Cardiol Coll 51 (2008) 1704-1706
13. Hundley G.H., Kizilbash A.M., Afridi I., Fatima F., Peshock R.M., and Grayburn P.A. Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging. J Am Coll Cardiol 32 (1998) 1426-1432
14. Thompson H.L., Basmadjian A.J., Rainbird A.J., Rasavi M., Avierinos J.F., Pellikka P.A., Bailey K.R., Breen J.F., and Enriquez-Sarano M. Contrast echocardiography improves the accuracy and reproducibility of left ventricular remodeling measurements: a prospective; randomly assigned, blinded study. J Am Coll Cardiol 38 (2001) 867-875
15. Malm S., Frigstad S., Sagberg E., Larsson H., and Skjaerpe T. Accurate and reproducible measurement of left ventricular volume and ejection fraction by contrast echocardiography. J Am Coll Cardiol 44 (2004) 1030-1035
16. Nayyar S., Magalski A., Khumri T.M., Idupulapati M., Stoner C.N., Kusnetzky L.L., Coggins T.R., Morris B.A., and Main M.L. Contrast administration reduces interobserver variability in determination of left ventricular ejection fraction in patients with left ventricular dysfunction and good baseline endocardial border delineation. Am J Cardiol 98 (2006) 1110-1114